Hot News

復星醫藥擬出售資產優勢眾多股價漲停 @ 2013-10-22T04: Back Hot News
Keyword:復星醫藥
Concept:3億8800萬歐元出售 , 億歐元售兩化合物知識產權
    新華網消息 10月20日晚,復星醫藥公告稱孫公司重慶復創擬向瑞士醫藥企業SELLAS轉讓兩個化合物全球范圍內的開發、銷售等權利,轉讓價格共約3.88億歐元,依研發進度分期支付。產品美國/歐洲獲批後,重慶復創獲得淨銷售額10%提成,並有權獲得擁有該兩個化合物的SELLAS子公司3%的權益。
消息面上,復星醫藥披露,擬向瑞士醫藥企業SELLAS轉讓兩項化合物的國外權益。轉讓代價為3.88億歐元(約41.17億港元),款項將按臨床試驗進展分期支付。兩項化合物,分別為治療腫瘤及糖尿病的潛在藥物。來源中國網)

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.